Cellosaurus logo
expasy logo

Cellosaurus ES-5838 (CVCL_6255)

[Text version]
Cell line name ES-5838
Synonyms 5838 Ewing's; 5838; #5838
Accession CVCL_6255
Resource Identification Initiative To cite this cell line use: ES-5838 (RRID:CVCL_6255)
Comments Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Disease Ewing sarcoma (NCIt: C4817)
Ewing sarcoma (ORDO: Orphanet_319)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 27Y
Category Cancer cell line
STR profile Source(s): PubMed=30879952

Markers:
AmelogeninX,Y
CSF1PO11
D3S135816
D5S81810
D7S82011
D13S31713
D16S5399,11
FGA20,22
TH019.3
TPOX8
vWA15,18

Run an STR similarity search on this cell line
Publications

PubMed=327080; DOI=10.1093/jnci/59.1.221
Fogh J., Fogh J.M., Orfeo T.
One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice.
J. Natl. Cancer Inst. 59:221-226(1977)

PubMed=6750238
Dickman P.S., Liotta L.A., Triche T.J.
Ewing's sarcoma. Characterization in established cultures and evidence of its histogenesis.
Lab. Invest. 47:375-382(1982)

PubMed=3004699; DOI=10.1016/0165-4608(86)90001-4
Whang-Peng J., Triche T.J., Knutsen T., Miser J.S., Kao-Shan S., Tsai S., Israel M.A.
Cytogenetic characterization of selected small round cell tumors of childhood.
Cancer Genet. Cytogenet. 21:185-208(1986)

PubMed=3518877; DOI=10.3109/07357908609038260
Fogh J.
Human tumor lines for cancer research.
Cancer Invest. 4:157-184(1986)

PubMed=3390826
McKeon C., Thiele C.J., Ross R.A., Kwan M., Triche T.J., Miser J.S., Israel M.A.
Indistinguishable patterns of protooncogene expression in two distinct but closely related tumors: Ewing's sarcoma and neuroepithelioma.
Cancer Res. 48:4307-4311(1988)

PubMed=2620246; DOI=10.3109/07357908909041371
Gulati S.C., Kwon J.-H., Atzpodien J., Triche T.J., Colvin O.M., Clarkson B.D. Sr.
In vitro chemosensitivity of two Ewing's sarcoma cell lines: implication for autologous bone marrow transplantation.
Cancer Invest. 7:411-416(1989)

PubMed=29464090; DOI=10.18632/oncotarget.23815
Spurny C., Kailayangiri S., Altvater B., Jamitzky S., Hartmann W., Wardelmann E., Ranft A., Dirksen U., Amler S., Hardes J., Fluegge M., Meltzer J., Farwick N., Greune L., Rossig C.
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G.
Oncotarget 9:6536-6549(2018)

PubMed=30879952; DOI=10.1016/j.ymthe.2019.02.014
Kailayangiri S., Altvater B., Lesch S., Balbach S.T., Gottlich C., Kuhnemundt J., Mikesch J.-H., Schelhaas S., Jamitzky S., Meltzer J., Farwick N., Greune L., Fluegge M., Kerl K., Lode H.N., Siebert N., Muller I., Walles H., Hartmann W., Rossig C.
EZH2 inhibition in Ewing sarcoma upregulates GD2 expression for targeting with gene-modified T cells.
Mol. Ther. 27:933-946(2019)

Cross-references
Cell line databases/resources Lonza; 628
Encyclopedic resources Wikidata; Q54832442
Polymorphism and mutation databases Cosmic; 1079353
Entry history
Entry creation04-Apr-2012
Last entry update29-Jun-2023
Version number15